Company Profile

Nuwellis is a commercial stage company focused on commercializing the Aquadex SmartFlow® System. Our objective is to improve the quality of life for patients with heart failure and related conditions, such as fluid overload. Nuwellis is listed on the NASDAQ Capital Market.

2023 Letter to Stockholders



Jul 19, 2024 5:42 AM EDT

Data provided by Refinitiv. Minimum 15 minutes delayed.

Stock information



History of Transforming Care

Our passion and expertise are grounded in a rich history of innovation and evolution. Since our inception in 1999, we have focused our efforts on understanding and meeting the critical needs associated with the treatment of fluid overload.





Events & Presentations

May 7, 2024 9:00 AM EDT